AS

Aditya Soni

Active Director Director DIN 08595464
DIN 08595464 First appointment Sep 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2019
Shareholding value •••• Premium profile

About Aditya Soni

Data last updated:

Aditya Soni is a Director at Precise Pharmaceuticals Private Limited (since 2019). The company operates in Pharma. Precise Pharmaceuticals Private Limited reported revenue of ₹1.85 Cr (FY 2024).

DIN 08595464
Primary Designation Director
Industry Pharma
First Appointment 25 Sep 2019
Oldest Company Age 33 yrs
Largest company Precise Pharmaceuticals Private Limited · ₹1.85 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Sep 20191993₹1.85 Cr (FY 2024)Active

Board colleagues of Aditya Soni

NameDINCompanyDesignation
Satish Soni00399084Precise Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Precise Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Aditya Soni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aditya Soni

Aditya Soni currently holds 1 directorship: Precise Pharmaceuticals Private Limited (Director, since 25 Sep 2019, revenue ₹1.85 Cr (FY 2024)).

Aditya Soni was first appointed on 25 Sep 2019 as Director at Precise Pharmaceuticals Private Limited.

The current boards of Aditya Soni's companies include Satish Soni (Precise Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available